Now showing items 1-5 of 5

    • Antifungal efficacy of F10SC veterinary disinfectant against Batrachochytrium dendrobatidis 

      De Jong, M.S.; Van Dyk, R.; Weldon, C. (Oxford Univ Press, 2018)
      The Infectious disease chytridiomycosis, which is caused by the fungal pathogen Batrachochytrium dendrobatidis, has been identified as one of the most important drivers of amphibian declines and extinction. In vitro B. ...
    • Elucidating the antimicrobial mechanisms of colistin sulfate on Mycobacterium tuberculosis using metabolomics 

      Koen, Nadia; Loots, Du Toit; Van Breda, Shane Vontelin (Elsevier, 2018)
      Considering the disadvantageous of first line anti-tuberculosis (TB) drugs, including poor patient adherence, drug side effects, the long treatment duration and rapidly increasing microbe resistance, alternative treatment ...
    • Metabolomics and personalized medicine 

      Koen, Nadia; Du Preez, Ilse; Loots, Du Toit (Elsevier, 2016)
      Current clinical practice strongly relies on the prognosis, diagnosis, and treatment of diseases using methods determined and averaged for the specific diseased cohort/population. Although this approach complies positively ...
    • Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis 

      Koen, Nadia; Van Breda, Shane Vontelin; Loots, Du Toit (Elsevier, 2018)
      Over the past 5 years, there has been a renewed interest in finding new compounds with anti-TB action. Colistin methanesulfonate or polymyxin E, is a possible anti-TB drug candidate, which may in future be used either alone ...
    • The role of metabolomics in tuberculosis treatment research 

      Luies, Laneke; Du Preez, Ilse; Loots, Du Toit (Future Medicine, 2017)
      Despite the fact that tuberculosis (TB) is a curable disease, it still results in approximately 1.8 million deaths annually. Various inadequacies in the current TB treatment strategies are major contributors to this high ...